JP2011520813A5 - - Google Patents

Download PDF

Info

Publication number
JP2011520813A5
JP2011520813A5 JP2011508670A JP2011508670A JP2011520813A5 JP 2011520813 A5 JP2011520813 A5 JP 2011520813A5 JP 2011508670 A JP2011508670 A JP 2011508670A JP 2011508670 A JP2011508670 A JP 2011508670A JP 2011520813 A5 JP2011520813 A5 JP 2011520813A5
Authority
JP
Japan
Prior art keywords
nucleic acid
particles
peptide
acid complex
polysaccharide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011508670A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011520813A (ja
JP5763525B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/043158 external-priority patent/WO2009137689A2/en
Publication of JP2011520813A publication Critical patent/JP2011520813A/ja
Publication of JP2011520813A5 publication Critical patent/JP2011520813A5/ja
Application granted granted Critical
Publication of JP5763525B2 publication Critical patent/JP5763525B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011508670A 2008-05-07 2009-05-07 粒子からの核酸複合体の送達 Expired - Fee Related JP5763525B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US5104108P 2008-05-07 2008-05-07
US61/051,041 2008-05-07
PCT/US2009/043158 WO2009137689A2 (en) 2008-05-07 2009-05-07 Delivery of nucleic acid complexes from particles

Publications (3)

Publication Number Publication Date
JP2011520813A JP2011520813A (ja) 2011-07-21
JP2011520813A5 true JP2011520813A5 (OSRAM) 2012-06-28
JP5763525B2 JP5763525B2 (ja) 2015-08-12

Family

ID=40910992

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011508670A Expired - Fee Related JP5763525B2 (ja) 2008-05-07 2009-05-07 粒子からの核酸複合体の送達

Country Status (5)

Country Link
US (1) US8936811B2 (OSRAM)
EP (1) EP2296630A2 (OSRAM)
JP (1) JP5763525B2 (OSRAM)
CA (1) CA2723192A1 (OSRAM)
WO (1) WO2009137689A2 (OSRAM)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2723192A1 (en) 2008-05-07 2009-11-12 Surmodics, Inc. Delivery of nucleic acid complexes from particles
US20110268772A1 (en) * 2008-12-26 2011-11-03 Samyang Corporation Pharmaceutical composition containing an anionic drug and a production method thereof
CA2758260A1 (en) 2009-04-08 2010-10-14 Surmodics, Inc. Controlled release devices and methods for delivery of nucleic acids
US8883208B2 (en) 2009-04-08 2014-11-11 Surmodics, Inc. Particles for delivery of nucleic acids and related devices and methods
EP2386647A1 (de) * 2010-05-10 2011-11-16 Qiagen GmbH Verfahren zur Transfektion einer eurkaryotischen Zelle
US20110319473A1 (en) * 2010-06-29 2011-12-29 Surmodics, Inc. Compositions and methods for enhancement of nucleic acid delivery
US8946170B2 (en) * 2010-07-21 2015-02-03 Allergan, Inc. Sustained release siRNA for ocular drug delivery
JP5812537B2 (ja) * 2010-11-05 2015-11-17 江崎グリコ株式会社 アミノ糖含有グルカン、その製造法および利用
US8901092B2 (en) 2010-12-29 2014-12-02 Surmodics, Inc. Functionalized polysaccharides for active agent delivery
US9828620B2 (en) 2013-06-28 2017-11-28 Verily Life Sciences Llc Porous polymeric formulation prepared using monomer
US9750445B2 (en) 2013-06-28 2017-09-05 Verily Life Sciences Llc Porous polymeric formulation prepared using porogens
US9551680B2 (en) 2013-06-28 2017-01-24 Verily Life Sciences Llc Chemically reactive enzyme immobilization
US9441258B2 (en) * 2013-06-28 2016-09-13 Verily Life Sciences LLP Enzyme immobilization by crosslinking
CN105764491A (zh) 2013-12-09 2016-07-13 度瑞公司 药物活性剂复合物、聚合物复合物,以及包括其的组合物和方法
US9987228B2 (en) 2014-11-18 2018-06-05 National Institute For Materials Science Method for producing porous particle
CA3008788C (en) * 2015-12-18 2021-05-25 Samyang Biopharmaceuticals Corporation Method for preparing polymeric micelles containing an anionic drug
KR101882133B1 (ko) * 2017-02-21 2018-07-25 성균관대학교산학협력단 핵산과 결합 가능한 펩타이드를 이용하여 핵산을 분리하는 방법
US11607388B2 (en) 2017-12-18 2023-03-21 C.R. Bard, Inc. Drug-loaded microbead compositions, embolization compositions and associated methods
US11590080B2 (en) 2017-12-18 2023-02-28 C.R. Bard, Inc. Drug-loaded biodegradable microbead compositions including drug-containing vesicular agents
WO2021072385A1 (en) * 2019-10-10 2021-04-15 University Of Maryland, Baltimore Compositions and methods for delivering nucleic acids to cells
US20220313616A1 (en) * 2021-03-30 2022-10-06 Celanese Eva Performance Polymers Llc Implantable Medical Device for the Delivery of Nucleic Acid-Encapsulated Particles
CN118879783B (zh) * 2024-07-04 2025-08-08 恒敬合创生物医药(浙江)有限公司 一种用于包裹核酸药物的环状脂肽载体

Family Cites Families (107)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2668156A (en) 1950-04-06 1954-02-02 Nat Starch Products Inc Unsaturated starch compounds and insoluble derivatives thereof
US4060506A (en) 1976-04-27 1977-11-29 A. E. Staley Manufacturing Company Starch acrylamides and the method for preparing the same
US4079025A (en) 1976-04-27 1978-03-14 A. E. Staley Manufacturing Company Copolymerized starch composition
US4638045A (en) 1985-02-19 1987-01-20 Massachusetts Institute Of Technology Non-peptide polyamino acid bioerodible polymers
US5160745A (en) 1986-05-16 1992-11-03 The University Of Kentucky Research Foundation Biodegradable microspheres as a carrier for macromolecules
DK0471036T4 (da) 1989-05-04 2004-07-19 Southern Res Inst Indkapslingsfremgangsmåde
EP0405917A1 (en) 1989-06-26 1991-01-02 Sequa Chemicals Inc. Starch polymer graft
US5116927A (en) 1989-06-27 1992-05-26 Sequa Chemicals, Inc. Starch polymer graft composition and method of preparation
IL98087A (en) 1990-05-04 1996-11-14 Perio Prod Ltd Preparation for dispensing drugs in the colon
US5626863A (en) 1992-02-28 1997-05-06 Board Of Regents, The University Of Texas System Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers
US5736371A (en) 1991-06-04 1998-04-07 A Et S Biovecteurs Biodegradable particulate vector for transporting molecules having biological activity
CA2121129A1 (en) 1991-10-29 1993-05-13 Patrick Soon-Shiong Crosslinkable polysaccharides, polycations and lipids useful for encapsulation and drug release
ATE192487T1 (de) 1992-02-13 2000-05-15 Surmodics Inc Immobilisierung eines chemischen spezies in einer vernetzten matrix
DE4210334A1 (de) 1992-03-30 1993-10-07 Stoess & Co Gelatine Biologisch abbaubares, wasserresistentes Polymer-Material
US6277899B1 (en) 1992-08-03 2001-08-21 Novamont S.P.A. Biodegradable polymeric composition
US5514379A (en) 1992-08-07 1996-05-07 The General Hospital Corporation Hydrogel compositions and methods of use
US5414075A (en) 1992-11-06 1995-05-09 Bsi Corporation Restrained multifunctional reagent for surface modification
US5272181A (en) 1992-11-18 1993-12-21 Evergreen Solutions, Inc. Biodegradable expanded foam material
ES2102186T3 (es) 1992-11-30 1997-07-16 Ciba Geigy Ag Esteres de hidratos de carbono polimerizables, polimeros de los mismos y su empleo.
SE500964C2 (sv) 1993-01-19 1994-10-10 Medicarb Ab Fast bärare med modifierad yta varvid modifikationen åstadkommes genom en primer innehållande en polysackarid och förfarande för framställning av en sådan bärare
US5589577A (en) 1993-04-07 1996-12-31 Alko Group Ltd. Applications and methods for the preparation of fatty acid esters of polysaccharides
US5773021A (en) 1994-03-14 1998-06-30 Vetoquinol S.A. Bioadhesive ophthalmic insert
US5466233A (en) 1994-04-25 1995-11-14 Escalon Ophthalmics, Inc. Tack for intraocular drug delivery and method for inserting and removing same
EP0712635B1 (en) 1994-05-13 2003-05-02 Kuraray Co., Ltd. Medical polymer gel
JPH11505505A (ja) 1994-06-27 1999-05-21 ザ・ジョンズ・ホプキンス・ユニバーシティー ターゲッティングされた遺伝子輸送システム
GB9514285D0 (en) 1995-07-13 1995-09-13 Univ Nottingham Polymeric lamellar substrate particles for drug delivery
TW362100B (en) 1995-07-21 1999-06-21 Novartis Ag The preparation and use of photochemically cross-linked polysaccharide derivatives having no photopolymerisable functional groups
JP2997995B2 (ja) 1995-09-13 2000-01-11 日本コーンスターチ株式会社 生分解性樹脂組成物の水系分散液
US5714360A (en) 1995-11-03 1998-02-03 Bsi Corporation Photoactivatable water soluble cross-linking agents containing an onium group
CA2173818A1 (fr) 1996-04-10 1997-10-11 Francois Chouinard Comprime pharmaceutique a liberation controlee contenant un support a base d'amylose reticule et d'hydroxypropylmethylcellulose
US20080131512A1 (en) 1996-07-01 2008-06-05 Wilhelmus Everhardus Hennink Biodegradable hydrogels
US5980948A (en) 1996-08-16 1999-11-09 Osteotech, Inc. Polyetherester copolymers as drug delivery matrices
FR2753902B1 (fr) 1996-09-27 1999-04-02 Ioualalen Karim Nouveau type de matrice ionique biodegradable de polarite interne modulable a polymere greffe
US5879707A (en) 1996-10-30 1999-03-09 Universite De Montreal Substituted amylose as a matrix for sustained drug release
EP0842657A1 (en) 1996-11-19 1998-05-20 OctoPlus B.V. Microspheres for controlled release and processes to prepare these microspheres
US5866165A (en) 1997-01-15 1999-02-02 Orquest, Inc. Collagen-polysaccharide matrix for bone and cartilage repair
JP3033508B2 (ja) 1997-01-20 2000-04-17 日本電気株式会社 生体内活動部位推定方法
US6613563B1 (en) * 1997-03-14 2003-09-02 Selective Gentics, Inc. Viral vectors with modified tropism
US20020039594A1 (en) 1997-05-13 2002-04-04 Evan C. Unger Solid porous matrices and methods of making and using the same
US6121027A (en) 1997-08-15 2000-09-19 Surmodics, Inc. Polybifunctional reagent having a polymeric backbone and photoreactive moieties and bioactive groups
US6316522B1 (en) 1997-08-18 2001-11-13 Scimed Life Systems, Inc. Bioresorbable hydrogel compositions for implantable prostheses
DE19737481A1 (de) 1997-08-28 1999-03-04 Hoechst Ag Sphärische lineare Polysaccharide enthaltende Mikropartikel
US6284273B1 (en) 1998-02-24 2001-09-04 Vincent Lenaerts Cross-linked high amylose starch resistant to amylase as a matrix for the slow release of biologically active compounds
US6007833A (en) 1998-03-19 1999-12-28 Surmodics, Inc. Crosslinkable macromers bearing initiator groups
US6410044B1 (en) 1998-03-19 2002-06-25 Surmodics, Inc. Crosslinkable macromers
FR2780901B1 (fr) 1998-07-09 2000-09-29 Coletica Particules, en particulier micro- ou nanoparticules de monosaccharides et oligosaccharides reticules, leurs procedes de preparation et compositions cosmetiques, pharmaceutiques ou alimentaires en contenant
AU5006999A (en) 1998-07-23 2000-02-14 Johns Hopkins University School Of Medicine, The Controlled release of bioactive substances
ID27960A (id) 1998-07-23 2001-05-03 Avebe B A Komposisi perekat
US6514534B1 (en) 1998-08-14 2003-02-04 Incept Llc Methods for forming regional tissue adherent barriers and drug delivery systems
IT1303553B1 (it) 1998-09-01 2000-11-14 Novamont Spa Composizioni biodegradabili comprendenti amido ed esteri di cellulosa.
US6596699B2 (en) 1998-09-22 2003-07-22 Biosurface Engineering Technologies, Inc. Nucleic acid coating compositions and methods
US6395029B1 (en) 1999-01-19 2002-05-28 The Children's Hospital Of Philadelphia Sustained delivery of polyionic bioactive agents
EP1156812A4 (en) 1999-02-23 2004-09-29 Isis Pharmaceuticals Inc MULTIPARTICULAR FORMULATION
US6716445B2 (en) 1999-04-12 2004-04-06 Cornell Research Foundation, Inc. Hydrogel entrapping therapeutic agent and stent with coating comprising this
ES2298135T3 (es) 1999-04-12 2008-05-16 Cornell Research Foundation, Inc. Sistema formador de hidrogel con componentes hidrofobos e hidrofilos.
ES2207123T3 (es) 1999-06-14 2004-05-16 Baxter International Inc. Microesferas de liberacion sostenida.
US6770740B1 (en) 1999-07-13 2004-08-03 The Regents Of The University Of Michigan Crosslinked DNA condensate compositions and gene delivery methods
US7030097B1 (en) 1999-07-14 2006-04-18 Cornell Research Foundation, Inc. Controlled nucleic acid delivery systems
DE60141334D1 (de) 2000-07-17 2010-04-01 Ezaki Glico Co Biologisch abbaubare artikel aus enzymatisch hergestellter amylose
WO2002017831A2 (en) 2000-08-30 2002-03-07 John Hopkins University Devices for intraocular drug delivery
EP1322337A2 (en) 2000-09-25 2003-07-02 Board of Regents, The University of Texas System Pei : dna vector formulations for in vitro and in vivo gene delivery
SE517421C2 (sv) 2000-10-06 2002-06-04 Bioglan Ab Mikropartiklar, lämpade för parenteral administration, väsentligen bestående av stärkelse med minst 85 % amylopektin och med reducerad molekylvikt, samt framställning därav
US6748954B2 (en) 2000-10-27 2004-06-15 The Regents Of The University Of Michigan Drug release from polymer matrices through mechanical stimulation
US6586493B1 (en) 2001-03-07 2003-07-01 Arizona Board Of Regents Arizona State University Polysaccharide-based hydrogels and pre-gel blends for the same
EP2316394B1 (en) 2001-06-12 2016-11-23 The Johns Hopkins University Reservoir device for intraocular drug delivery
US20040063654A1 (en) 2001-11-02 2004-04-01 Davis Mark E. Methods and compositions for therapeutic use of RNA interference
WO2003088925A2 (en) * 2002-04-18 2003-10-30 Carnegie Mellon University Method of manufacturing hydroxyapatite and uses therefor in delivery of nucleic acids
US20030218130A1 (en) 2002-05-02 2003-11-27 Ciphergen Biosystems, Inc. Biochips with surfaces coated with polysaccharide-based hydrogels
US6715445B2 (en) * 2002-05-07 2004-04-06 Rolf C. Hagen, Inc. Bird cage
DE10223310A1 (de) 2002-05-24 2003-12-11 Biotronik Mess & Therapieg Verfahren zum Beschichten von Implantaten mit einer Polysaccharid-Lage
SE0201863D0 (en) 2002-06-18 2002-06-18 Cepep Ab Cell penetrating peptides
CN100519643C (zh) 2002-07-19 2009-07-29 奥默罗斯公司 可生物降解的三嵌段共聚物,它们的合成方法和从它制得的水凝胶和生物材料
US7862831B2 (en) 2002-10-09 2011-01-04 Synthasome, Inc. Method and material for enhanced tissue-biomaterial integration
US20040062778A1 (en) 2002-09-26 2004-04-01 Adi Shefer Surface dissolution and/or bulk erosion controlled release compositions and devices
US20050143363A1 (en) 2002-09-29 2005-06-30 Innorx, Inc. Method for subretinal administration of therapeutics including steroids; method for localizing pharmacodynamic action at the choroid of the retina; and related methods for treatment and/or prevention of retinal diseases
WO2004056311A2 (en) 2002-12-17 2004-07-08 Massachusetts Institute Of Technology Stimuli-responsive systems for controlled drug delivery
US20050025797A1 (en) 2003-04-08 2005-02-03 Xingwu Wang Medical device with low magnetic susceptibility
ATE476960T1 (de) 2003-05-02 2010-08-15 Surmodics Inc System zur kontrollierten freisetzung eines bioaktiven wirkstoffs im hinteren bereich des auges
AU2004280158B2 (en) * 2003-07-18 2011-02-17 Baxter International, Inc. Methods for fabrication, uses and compositions of small spherical particles prepared by controlled phase separation
EP1555278A1 (en) 2004-01-15 2005-07-20 Innocore Technologies B.V. Biodegradable multi-block co-polymers
US7514530B2 (en) 2004-04-26 2009-04-07 Centre National De La Recherche Scientifique Peptide carrier for delivering siRNA into mammalian cells
WO2005113034A1 (en) 2004-05-12 2005-12-01 Surmodics, Inc. Natural biodegradable polysaccharides coatings for medical articles
DK1765294T3 (da) 2004-05-12 2008-11-10 Baxter Int Nukleinsyremikrokugler samt deres fremstilling og afgivelse
US7740861B2 (en) 2004-06-16 2010-06-22 University Of Massachusetts Drug delivery product and methods
US20060110428A1 (en) 2004-07-02 2006-05-25 Eugene Dejuan Methods and devices for the treatment of ocular conditions
CA2575984C (en) 2004-08-12 2011-02-08 The Sherwin-Williams Company Carbohydrate based alkyds
MX2007006214A (es) 2004-11-24 2008-04-16 Therakine Ltd Un implante para suministro de farmaco intraocular.
US20060286071A1 (en) 2005-06-21 2006-12-21 Epstein Samuel J Therapeutic pastes for medical device coating
US8663673B2 (en) 2005-07-29 2014-03-04 Surmodics, Inc. Devices, articles, coatings, and methods for controlled active agent release or hemocompatibility
WO2007040557A1 (en) 2005-09-21 2007-04-12 Surmodics, Inc. Coatings and articles including natural biodegradable polysaccharides
WO2007038126A1 (en) 2005-09-21 2007-04-05 Surmodics, Inc. In vivo formed matrices including natural biodegradable polysaccharides and ophthalmic uses thereof
US8166909B2 (en) 2005-11-15 2012-05-01 Surmodics, Inc. Apparatus and methods for applying coatings
EP1986603A2 (en) 2006-01-13 2008-11-05 SurModics, Inc. Microparticle containing matrices for drug delivery
EP1984399A4 (en) 2006-02-10 2010-03-03 Univ California TRANSDUCIBLABLE DELIVERY OF SIRANA BY MEANS OF DSRNA BINDEDOMADE FUSIONS TO PTD / CPPS
JP2009529967A (ja) 2006-03-15 2009-08-27 サーモディクス,インコーポレイティド 天然生分解性ポリサッカライドの疎水性誘導体及びそれらの使用
WO2008003043A2 (en) 2006-06-28 2008-01-03 Surmodics, Inc. Combination degradable and non-degradable matrices for active agent delivery
EP2037977A2 (en) 2006-06-28 2009-03-25 SurModics, Inc. Active agent eluting matrices with particulates
CN105168146A (zh) * 2006-08-04 2015-12-23 巴克斯特国际公司 预防和/或逆转新发作自身免疫糖尿病的基于微球的组合物
WO2008060359A2 (en) 2006-09-29 2008-05-22 Surmodics, Inc. Biodegradable ocular implants and methods for treating ocular conditions
WO2008073295A2 (en) 2006-12-07 2008-06-19 Surmodics, Inc. Latent stabilization of bioactive agents releasable from implantable medical articles
US8709827B2 (en) 2007-06-28 2014-04-29 Surmodics, Inc. Polypeptide microparticles
CA2705520C (en) 2007-11-13 2016-06-28 Surmodics Pharmaceuticals, Inc. Viscous terpolymers as drug delivery platform
JP2011509944A (ja) 2008-01-14 2011-03-31 サーモディクス,インコーポレイティド 核酸送達複合体の溶出のための装置及び方法
CA2723192A1 (en) 2008-05-07 2009-11-12 Surmodics, Inc. Delivery of nucleic acid complexes from particles
US20110159098A1 (en) 2009-12-30 2011-06-30 Surmodics, Inc. Stabilization and delivery of nucleic acid complexes
US20110319473A1 (en) 2010-06-29 2011-12-29 Surmodics, Inc. Compositions and methods for enhancement of nucleic acid delivery
US8901092B2 (en) 2010-12-29 2014-12-02 Surmodics, Inc. Functionalized polysaccharides for active agent delivery

Similar Documents

Publication Publication Date Title
JP2011520813A5 (OSRAM)
Fong et al. Responsive self-assembled nanostructured lipid systems for drug delivery and diagnostics
Davoudi et al. Intestinal organoids containing poly (lactic‐co‐glycolic acid) nanoparticles for the treatment of inflammatory bowel diseases
Fan et al. Formation mechanism of monodisperse, low molecular weight chitosan nanoparticles by ionic gelation technique
Meyer et al. Biomimetic particles as therapeutics
Raja et al. Polymeric nanomaterials: methods of preparation and characterization
Shin et al. Aspect ratio-controlled synthesis of uniform colloidal block copolymer ellipsoids from evaporative emulsions
Colombani et al. Structure of micelles of poly (n-butyl acrylate)-block-poly (acrylic acid) diblock copolymers in aqueous solution
Zhu et al. Hollow mesoporous silica/poly (l-lysine) particles for codelivery of drug and gene with enzyme-triggered release property
JP2015500342A5 (OSRAM)
Lv et al. Stimuli-selective delivery of two payloads from dual responsive nanocontainers
Min et al. Computer simulations on the pH-sensitive tri-block copolymer containing zwitterionic sulfobetaine as a novel anti-cancer drug carrier
Rungnim et al. pH-controlled doxorubicin anticancer loading and release from carbon nanotube noncovalently modified by chitosan: MD simulations
Kim et al. Production of CNT-taxol-embedded PCL microspheres using an ammonium-based room temperature ionic liquid: as a sustained drug delivery system
JP2016523833A5 (OSRAM)
Barros et al. A review of solute encapsulating nanoparticles used as delivery systems with emphasis on branched amphipathic peptide capsules
Mishra et al. Synthesis of poly [3‐(methacryloylamino) propyl trimethylammonium chloride‐co‐methacrylic acid] copolymer hydrogels for controlled indomethacin delivery
Wang et al. Application of mesoscale simulation to explore the aggregate morphology of pH-sensitive nanoparticles used as the oral drug delivery carriers under different conditions
Asadzadeh et al. Investigation of the interactions between Melittin and the PLGA and PLA polymers: molecular dynamic simulation and binding free energy calculation
Lima et al. Design advances in particulate systems for biomedical applications
CN102423299A (zh) 一种新型壳聚糖纳米载药微球的制备方法
CN102286155B (zh) 一种海藻酸钠-碳酸钙杂化微米粒子的制备方法
CN102432736B (zh) 一种单分散分子印迹聚合物纳米微球的制备方法
JP2015517390A5 (OSRAM)
Akgün et al. Perspectives of Aerosol‐Photopolymerization: Nanostructured Polymeric Particles